-
CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer
2026-09-20
The reference study identifies CLK2 as a mediator of platinum resistance in ovarian cancer and links its activity to phosphorylation of BRCA1 at Ser1423 and enhanced DNA damage repair. Its combination of tissue profiling, cellular assays, mechanistic analysis, and xenograft validation provides a framework for evaluating CLK2 as a treatment-resistance target, while also defining important limits for translating broad Cdc2-like kinase pharmacology into a CLK2-specific conclusion.
-
BipD Hijacks Mitophagy in B. pseudomallei Infection
2026-09-19
The reference study identifies the Burkholderia pseudomallei type III secretion system protein BipD as an effector that redirects host mitophagy to support intracellular bacterial survival. Its mechanistic contribution is the definition of a BipD–KLHL9/KLHL13–CUL3 ubiquitination axis targeting IMMT at K211, linking mitochondrial ubiquitination, reduced mitochondrial ROS, and evasion of macrophage killing.
-
EdU Flow Cytometry Assay Kits (Cy5) for S-Phase
2026-09-19
EdU Flow Cytometry Assay Kits (Cy5) enable denaturation-free measurement of DNA synthesis, making them useful for multiplexed cell-cycle, immunophenotyping, and pharmacodynamic workflows. This guide connects click chemistry DNA synthesis detection with colorectal cancer research and provides practical setup, optimization, and troubleshooting strategies.
-
ROS-Responsive Lipid Nanoparticles for RAS-Targeted mRNA
2026-09-18
Cai and colleagues developed a combinatorial library of thioketal-containing, ROS-degradable lipids to preferentially deliver mRNA into tumor cells. Their lead formulation, BAmP-TK-12, enabled delivery of DUF5 mRNA to deplete mutant RAS and produced stronger antitumor effects than a small-molecule RAS inhibitor in the reported models.
-
NSC 87877 for Shp2 Signaling Research
2026-09-17
NSC 87877 is a selective Shp2 inhibitor for connecting phosphatase activity with EGF–Ras–Erk signaling, microglial inflammation, and disease-relevant phenotypes. This workflow shows how to handle the compound, build target-engagement controls, and interpret results without overextending evidence from stroke, pain, or leukemia models.
-
Protein A/G Magnetic Co-IP/IP Kit for PINK1
2026-09-17
Translate UBC9–PINK1 interaction biology into a reproducible pull-down and immunoblot workflow using magnetic separation, controlled washes, and matched controls. The same platform also supports antibody purification and mass-spectrometry-ready complex isolation from cellular or tissue lysates.
-
EdU Imaging Kits (Cy5): Practical Workflow Guide
2026-09-16
EdU Imaging Kits (Cy5) provide a practical way to detect DNA synthesis during S-phase using EdU incorporation and Cy5 click-chemistry labeling. They are suitable for fluorescence microscopy and flow cytometry, but EdU signal alone should not be used as a direct measure of viability, total cell number, or the mechanism of genotoxicity.
-
EdU and IRE1α: Translating Proliferation Biology
2026-09-16
A translational framework for using EdU-based S-phase measurements to validate the verteporfin–IRE1α–AKT mechanism and strengthen pharmacodynamic, genotoxicity, and combination-treatment studies.
-
How α-Synuclein Condensates Sort Molecules
2026-09-15
A 2025 Journal of Biological Chemistry study shows that α-synuclein condensates possess a strongly negative electrostatic potential that controls how proteins, fluorophores, and other molecules partition into them. By combining charge-varied fluorescent probes, zeta-potential measurements, and a cellular condensate model, the authors connect condensate formation with electrostatic exclusion and enrichment.
-
N3-kethoxal: Guanine-Selective Nucleic Acid Probe
2026-09-15
N3-kethoxal is a membrane-permeable, azide-functionalized probe for labeling unpaired guanine in RNA and single-stranded DNA. Its covalent azide handle supports bioorthogonal click chemistry labeling, RNA secondary structure probing, and accessible-DNA mapping when paired with appropriate controls.
-
Y-27632 dihydrochloride Assay Guide
2026-09-14
A scenario-based guide to using Y-27632 dihydrochloride (SKU A3008) in cell viability, proliferation, cytotoxicity, and cytoskeletal assays. It connects ROCK biology with practical decisions about controls, stock preparation, data interpretation, and vendor selection.
-
Bestatin-Derived IRAP Inhibitors: Study Insights
2026-09-14
This study introduces a stereocontrolled strategy for functionalizing the α-hydroxy-β-amino acid scaffold of bestatin and applies it to selective inhibition of oxytocinase-family aminopeptidases. Structural, biochemical, and cellular data identify P1-side-chain interactions with the GAMEN loop as an important determinant of low-nanomolar IRAP inhibition and enzyme selectivity.
-
From Oxytocin Circuits to Amplified Evidence
2026-09-13
A mechanistic and translational analysis of how early life adversity alters oxytocin-linked visual defense circuits, and how Cyanine 3 Tyramide can help researchers convert subtle molecular changes into spatially resolved evidence.
-
CD28–ARS2 Splicing Reprograms CD8+ T Cells
2026-09-12
The reference study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and enables metabolic flexibility in activated CD8+ T cells. Its findings connect post-transcriptional RNA regulation with glucose utilization, interferon-γ production, and antitumor effector activity, while also separating this mechanism from canonical CD28–PI3K signaling.
-
TAK-715: Practical p38 MAPK Inhibition Workflows
2026-09-12
TAK-715 combines nanomolar p38α selectivity with a workflow-friendly profile for cytokine, inflammation, and rheumatoid arthritis research. Its use alongside phosphorylation and cytokine readouts can distinguish direct kinase inhibition from broader changes in p38 MAPK pathway regulation.